Westphal, Termeer Step Down From Verastem Board

Xconomy Boston — 

Cambridge, MA-based Verastem (NASDAQ: VSTM) has shaken up its board of directors. Christoph Westphal, who co-founded the company in 2010, ran it as chairman and CEO in its early days, and took the company public in 2012, has stepped down from the board, as has former Genzyme CEO Henri Termeer. Westphal moved from Verastem CEO to executive chairman in 2013, and is now the chairman and CEO of a different startup he also helped form, Flex Pharma (NASDAQ: FLKS). Verastem said that Bruce Wendel, the former CEO of Abraxis Bioscience, will join its board, and Michael Kauffman, who has been a director since November 2012, will now be a lead director.